FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells

被引:1
|
作者
Karmakar, Deepmala [1 ]
Lahiri, Pooja [2 ]
Bedi, Minakshi [1 ]
Ghosh, Aritri [3 ]
Ghosh, Alok [1 ]
Barui, Ananya [3 ]
Varshney, Shailendra Kumar [4 ]
Lahiri, Basudev [4 ]
Sengupta, Sanghamitra [1 ]
机构
[1] Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India
[2] IIT Kharagpur, Adv Technol Dev Ctr, Kharagpur, India
[3] Indian Inst Engn Sci & Technol, Ctr Healthcare Sci & Technol, Shibpur Bot Garden Rd, Howrah, W Bengal, India
[4] Indian Inst Technol Kharagpur, Dept Elect & Elect Commun Engn, Kharagpur, India
关键词
epithelial-to mesenchymal transition; FTIR spectroscopy; prostate cancer; spectral fingerprints; INFRARED-SPECTROSCOPY; EMT; METABOLISM; EXPRESSION; MEMBRANES; AXIS;
D O I
10.1002/jcb.30408
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The standard diagnosis of prostate cancer is accomplished by the identification of cytomorphological deviations in biopsied tissues while immunohistochemistry is used to resolve the equivocal cases. Accumulating evidence favors the concept that epithelial-to-mesenchymal transition (EMT) is a stochastic process composed of multiple intermediate states instead of a single binary switch. Despite its significant role in promoting cancer aggressiveness, the current tissue-based risk stratification tools do not include any of the EMT phenotypes as a metric. As a proof-of-concept, the present study analyzes the temporal progression of EMT in transforming growth factor-beta (TGF-beta) treated PC3 cells encompassing multifarious characteristics such as morphology, migration and invasion, gene expression, biochemical fingerprint, and metabolic activity. Our multimodal approach reinstates EMT plasticity in TGF-beta treated PC3 cells. Further, it highlights that mesenchymal transition is accompanied by discernible changes in cellular morphometry and molecular signatures particularly in the range of 1800-1600 cm(-1) and 3100-2800 cm(-1) of Fourier-transformed infrared (FTIR) spectra signifying Amide III and lipid, respectively. Investigation of attenuated total reflectance (ATR)-FTIR spectra of extracted lipids from PC3 cell populations undergoing EMT identifies changes in stretching vibration at FTIR peaks at 2852, 2870, 2920, 2931, 2954, and 3010 cm(-1) characteristics of fatty acids and cholesterol. Chemometric analysis of these spectra indicates that the level of unsaturation and acyl chain length of fatty acid coregister with differential epithelial/mesenchymal states of TGF-beta treated PC3 cells. Observed changes in lipids also correlate with cellular nicotinamide adenine dinucleotide hydrogen (NADH) and flavin adenine dinucleotide dihydrogen (FADH2) levels and mitochondrial oxygen consumption rate. In summary, our study establishes that morphological and phenotypic traits of epithelial/mesenchymal variants of PC3 cells concur with their respective biochemical and metabolic properties. It also underscores that spectroscopic histopathology has a definitive potential to refine the diagnosis of prostate cancer reckoning its molecular and biochemical heterogeneities.
引用
收藏
页码:849 / 860
页数:12
相关论文
共 50 条
  • [21] Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
    Park, So-Yeon
    Kim, Min-Jin
    Park, Sang-A
    Kim, Jung-Shin
    Min, Kyung-Nan
    Kim, Dae-Kee
    Lim, Woosung
    Nam, Jeong-Seok
    Sheen, Yhun Yhong
    ONCOTARGET, 2015, 6 (35) : 37535 - 37552
  • [22] Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells
    Chen Yumin
    Luo Qiong
    Xiong Zibo
    Liang Wei
    Chen Li
    Xiong Zuying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (06): : 522 - 529
  • [23] EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β
    Oktyabri, Dulamsuren
    Tange, Shoichiro
    Terashima, Minoru
    Ishimura, Akihiko
    Suzuki, Takeshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (01) : 124 - 130
  • [24] Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-β
    Guan, Feng
    Schaffer, Lana
    Handa, Kazuko
    Hakomori, Sen-itiroh
    FASEB JOURNAL, 2010, 24 (12) : 4889 - 4903
  • [25] TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops
    Zhang, Jingyu
    Tian, Xiao-Jun
    Zhang, Hang
    Teng, Yue
    Li, Ruoyan
    Bai, Fan
    Elankumaran, Subbiah
    Xing, Jianhua
    SCIENCE SIGNALING, 2014, 7 (345) : ra91
  • [26] TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
    Hua, Wan
    ten Dijke, Peter
    Kostidis, Sarantos
    Giera, Martin
    Hornsveld, Marten
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (11) : 2103 - 2123
  • [27] TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
    Wan Hua
    Peter ten Dijke
    Sarantos Kostidis
    Martin Giera
    Marten Hornsveld
    Cellular and Molecular Life Sciences, 2020, 77 : 2103 - 2123
  • [28] SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells
    Sun, Weichao
    Feng, Jianguo
    Yi, Qian
    Xu, Xichao
    Chen, Ying
    Tang, Liling
    BIOFACTORS, 2018, 44 (05) : 453 - 464
  • [29] Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors
    Wu, Kaijie
    Zeng, Jin
    Li, Lei
    Fan, Jinhai
    Zhang, Dong
    Xue, Yan
    Zhu, Guodong
    Yang, Lin
    Wang, Xinyang
    He, Dalin
    ONCOLOGY REPORTS, 2010, 23 (06) : 1545 - 1552
  • [30] The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells
    Fu, Jianjiang
    Ke, Xiaoqin
    Tan, Songlin
    Liu, Ting
    Wang, Shan
    Ma, Junchao
    Lu, Hong
    ONCOLOGY REPORTS, 2016, 35 (01) : 117 - 126